ADVANCED ANALYSIS FOR PRECISION CANCER THERAPY (ADAPT)

AMENDMENT 03 is being issued to update Volume 1: Administrative & National Policy Requirements Document Template. Specifically #3 has updated footnotes and directions for content and formatting instructions. Additionally, #10 Clinical Trial Protocol and Historical Trial Accrual Rates has been added to the document (TA2 applicability). 

----------------------------------------------------------------

AMENDMENT 02 is being issued to clarify additional technical and phase requirements within numerous areas of the Opportunity Description. Submission requirements have changed; see Section 5 for changes. All changes are illustrated in red font; word deletions are in red font with a strikethrough (i.e., example).

----------------------------------------------------------------

AMENDMENT 01 .... Read More

AMENDMENT 02 is being issued to clarify additional technical and phase requirements within numerous areas of the Opportunity Description. Submission requirements have changed; see Section 5 for changes. All changes are illustrated in red font; word deletions are in red font with a strikethrough (i.e., example).

----------------------------------------------------------------

AMENDMENT 01 is being issued to clarify technical and phase requirements within numerous areas of the Opportunity Description. All changes are illustrated in red font; word deletions are in red font with a strikethrough (i.e., example).   

-----------------------------------------------------------------

The mission of the Advanced Research Projects Agency for-Health (ARPA-H) is .... Read More